About: Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $7.19 (-2.18%)
KURA NASDAQ Kura Oncology Inc
Kura Oncology Inc share price
Atividade de preço de KURA
Último preço
$ 7,150
Variação (24h)
-0,20 USD (2,72%)
Volume
469.13K
Volume (média 4 sem.)
-
Abertura
$ 7,24
Variação do dia
$ 7,09 - $ 7,37
Fechamento anterior
$ 7,35
Último negócio
20 Nov, 4:49 pm GMT+0
Atrasado
20 Nov, 4:49 pm GMT+0
KURA price performance
Atrasado
20 Nov, 4:49 pm GMT+0
KURA details
quote.marketSignals